Skip to main content

Table 1 The percentages of maximum possible effect (%MPE), duration, and the area under the curves (AUCs) of mexiletine alone or co-administration of low dose mexiletine with dopamine or phenylephrine

From: A comparative study on the effect of dopamine vs phenylephrine in improving the cutaneous analgesic effect of mexiletine in rats

 

%MPE

Duration (min)

AUCs (%MPE × min)

Complete block time

Full recovery time

Mex 1.8 μmol

43.75 ± 7.00

0

13.75 ± 1.25

329.163 ± 69.53

Mex 1.8 μmol + Phe 0.0059 μmol

81.25 ± 3.78a

0

25.000 ± 0.94

1299.000 ± 136.66b

Mex 1.8 μmol + Phe 0.0295 μmol

95.83 ± 4.17ac

3.750 ± 1.25

40.00 ± 2.67ad

2211.875 ± 198.80ae

Mex 1.8 μmol + Phe 0.1473 μmol

100 ± 0ad

48.75 ± 1.57acf

82.500 ± 2.83adf

6811.375 ± 200.12af

Mex 1.8 μmol + Dop 0.06 μmol

100 ± 0ad

29.625 ± 3.56acfh

55.625 ± 3.20acgh

4414.75 ± 238.21acfh

Mex 1.8 μmol + Dop 0.60 μmol

100 ± 0ad

46.625 ± 4.07acfj

71.25 ± 3.75acfk

5780.25 ± 223.72acfij

Mex 1.8 μmol + Dop 6.00 μmol

100 ± 0ad

48.000 ± 2.67acfj

78.75 ± 62.45acfj

6467.750 ± 269.12acfj

  1. Data are expressed as mean ± SD (n = 8 in each group). Compared with Mex 1.8 μmol, ap < 0.001, bp < 0.05; compared with Mex 1.8 μmol + Phe 0.0059 μmol, cp < 0.001, dp < 0.01, ep < 0.05; compared with Mex 1.8 μmol + Phe 0.0295 μmol, fp < 0.001, gp < 0.01; compared with Mex 1.8 μmol + Phe 0.1473 μmol, hp < 0.001, ip < 0.05; compared with Mex 1.8 μmol + Dop 0.06 μmol, jp < 0.001, kp < 0.01. The data among the groups were analyzed using one-way ANOVA followed by Tukey’s honest significant difference (HSD) test for paired comparisons. Mex Mexiletine, Dop Dopamine, Phe Phenylephrine